aPatients were randomised 2:2:1 to the tiotropium Respimat 5 μg, tiotropium Respimat 2.5 μg and placebo Respimat groups, respectively. bAs determined by the investigator. cElevation of aspartate amino

NIAID Data Ecosystem20

邯郸市馆陶县-卫生-医院用药方法数据

临床用药管理

药物不良反应监测

馆陶县人民医院在开展医疗服务过程中产生的医院用药方法数据，包含药品名称、剂型剂量、给药途径、频次疗程、用药反应等。可用于合理用药指导、药效研究、不良反应监测。

河北省公共数据资源登记平台70

Rapid Ventricular Tachycardias Associated with Cilostazol Use

药物不良反应监测

心血管事件风险

A 92-year-old woman with normal systolic function had recently begun using the newly approved phosphodiesterase III inhibitor cilostazol when she was admitted with lower-extremity pain. Cilostazol is

PubMed Central30

Opinion on undisclosed side effects from medicines in India 2023

资源简介：

相关数据集